Elicitation of polyclonal cytotoxic T-responses to HER-2 in HLA-A0201 mice by a novel multiepitope peptide vaccine

被引：0
|
作者：
Dakappagari, N [1 ]
Kaumaya, PTP [1 ]
机构：
[1] Ohio State Univ, Arthur G James Comprehens Canc Ctr, Dept Obstet & Gynecol, Columbus, OH 43210 USA
来源：
BIOPOLYMERS | 2003年 / 71卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P484
引用
收藏
页码：407 / 407
页数：1
相关论文
共 50 条
  • [31] Peptide-specific cytotoxic T lymphocytes fail to recognize MAGE-A1+ or Her-2/neu+ tumor cell lines
    Kayser, S
    Rentzsch, C
    Stumm, S
    Wallwiener, D
    Gückel, B
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2003, 63 (11) : 1137 - 1145
  • [32] Antibody association with HER-2/neu-targeted vaccine enhances CD8+ T cell responses in mice through Fc-mediated activation of DCs
    Kim, Peter S.
    Armstrong, Todd D.
    Song, Hong
    Wolpoe, Matthew E.
    Weiss, Vivian
    Manning, Elizabeth A.
    Huang, Lan Qing
    Murata, Satoshi
    Sgouros, George
    Emens, Leisha A.
    Reilly, R. Todd
    Jaffee, Elizabeth M.
    JOURNAL OF CLINICAL INVESTIGATION, 2008, 118 (05): : 1700 - 1711
  • [33] Development of a novel PD-1 vaccine and in combination with two Chimeric HER-2 peptide vaccine provides synergistic inhibition of tumor growth in a syngeneic Balb/c model challenged with CT26/HER-2 carcinoma cell line
    Bekaii-Saab, Tanios
    Overholser, Jay
    Yang, Yuhong
    Penichet, Manuel
    Kaumaya, Pravin
    CANCER RESEARCH, 2019, 79 (13)
  • [34] A Novel Human Her-2/neu Chimeric Molecule Expressed by Listeria monocytogenes Can Elicit Potent HLA-A2 Restricted CD8-positive T cell Responses and Impact the Growth and Spread of Her-2/neu-positive Breast Tumors
    Seavey, Matthew M.
    Pan, Zhen-Kun
    Maciag, Paulo C.
    Wallecha, Anu
    Rivera, Sandra
    Paterson, Yvonne
    Shahabi, Vafa
    CLINICAL CANCER RESEARCH, 2009, 15 (03) : 924 - 932
  • [35] Her-2/neu-derived peptide epitopes are also recognized by cytotoxic CD3+CD56+ (natural killer T) lymphocytes
    Baxevanis, CN
    Gritzapis, AD
    Tsitsilonis, OE
    Katsoulas, HL
    Papamichail, M
    INTERNATIONAL JOURNAL OF CANCER, 2002, 98 (06) : 864 - 872
  • [36] A nano-liposome vaccine carrying E75, a HER-2/neu-derived peptide, exhibits significant antitumour activity in mice
    Arab, Atefeh
    Behravan, Javad
    Razazan, Atefeh
    Gholizadeh, Zahra
    Nikpoor, Amin Reza
    Barati, Nastaran
    Mosaffa, Fatemeh
    Badiee, Ali
    Jaafari, Mahmoud Reza
    JOURNAL OF DRUG TARGETING, 2018, 26 (04) : 365 - 372
  • [37] Natural T cell immunity to HER-2/NEU HLA class II peptide, p885-899, in patients with breast or ovarian cancer
    Formicola, Courtney A.
    Erskiner, Courtney L.
    Kalli, Kimberly R.
    Disis, Mary L.
    Yu, Chao
    Wettstein, Peter J.
    Ishioka, Glenn
    Knutson, Keith L.
    JOURNAL OF IMMUNOTHERAPY, 2007, 30 (08) : 894 - 895
  • [38] A novel virus-like particle vaccine presenting HER-2 extracellular domain elicits strong immune responses against mammary carcinoma
    Palladini, Arianna
    Thrane, Susan
    Janitzek, Christoph M.
    Pihl, Jessica
    Clemmensen, Stine B.
    de Jongh, Wilhelm A.
    Clausen, Thomas M.
    Nicoletti, Giordano
    Landuzzi, Lorena
    Penichet, Manuel L.
    Balboni, Tania
    Ianzano, Marianna L.
    Giusti, Veronica
    Theander, Thor H.
    Nielsen, Morten A.
    Salanti, Ali
    Lollini, Pier-Luigi
    Nanni, Patrizia
    Sander, Adam F.
    CANCER RESEARCH, 2018, 78 (13)
  • [39] Generation of genome-wide CD8 T cell responses in HLA-A*0201 transgenic mice by an HIV-1 ubiquitin expression library immunization vaccine
    Singh, RAK
    Wu, L
    Barry, MA
    JOURNAL OF IMMUNOLOGY, 2002, 168 (01): : 379 - 391
  • [40] Identification of a novel HLA-A*0201-restricted, cytotoxic T lymphocyte epitope in a human glioma-associated antigen, interleukin 13 receptor α2 chain
    Okano, F
    Storkus, WJ
    Chambers, WH
    Pollack, IF
    Okada, H
    CLINICAL CANCER RESEARCH, 2002, 8 (09) : 2851 - 2855
12345